GSK: Clinical Trials & Research Profile
Biopharma Industry (London, UK / Philadelphia, PA) · Primary Focus: Infectious Disease and Vaccines
| Clinical Trial Metric | Verified Public Record |
|---|---|
| Organization Type | Consolidated Trial Sponsor |
| Institutional Sector & Location | Biopharma Industry (London, UK / Philadelphia, PA) |
| Primary Therapeutic Area | Infectious Disease and Vaccines |
| Active Phase II & III Studies | 128 active (73 recruiting now) |
| Total Tracked Studies (2018 to 2026) | 304 (137 with California sites) |
| Completed vs Early-Stopped Studies | 130 completed / 46 stopped (15.1% stop rate) |
| Median Closed Enrollment | 284 participants |
| FDA Drugs@FDA Original Approvals | 116 all-time (13 from 2018 to 2026) |
| Physical Hospital Site Disclosure | 3.8% named hospital slots |
Related Filings Across Meru Platforms
Verified cross-ledger federal filings for GSK across sibling Meru public-data platforms.
Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI -> · AI for Healthcare · Healthcare Price & Patent Cliff Crosswalk